Clinical Trial Update: A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 [Phase 3]

View source ↗

Summary

This is a Phase 3 maintenance and long-term extension study evaluating the efficacy and safety of upadacitinib (ABT-494) in Crohn's disease patients who complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Crohn's Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING